Previous studies have suggested that intercellular ad¬ hesion molecule 1 46  24  49  20  27  54  65  5  52  49  34  50  67  5  52  54  23  40  7  38  17  53  30  30  42  54  50  49  1  38  68  18  50  10  44  23  48  37  52  63  43  60  38  61  23  45  69  27  25  26  40  24  57  60  49  65  29  5 The mean level ofserum sICAM-1 for the asthmatic patients (304.0 ±82.5 ng/mL) was significantly higher than that of the healthy volunteers (260.9±67.2 ng/ mL; p=0.004) (Fig 1) . Among the patients, 22 were considered to have atopic asthma based on the pres¬ ence of elevated specific IgE levels against housedust or mite antigens. The mean serum sICAM-1 level for these patients, 286.3 ±67.5 ng/mL, did not differ from that of 24 patients with nonatopic asthma, 282.7±57.0 ng/mL. Similarly, patients with total serum IgE levels of 400 lU/mL or more did not differ from those with less than 400 IU/mL in their levels of sICAM-1, and no correlation between serum IgE levels and sICAM-1 was detected by linear regression analysis.
In 14 patients whose serum sICAM-1 levels were measured both during asthma attacks and during remission, the levels were significantly higher during attacks (p=0.035; Fig 2) . Among these patients, those receiving corticosteroids (Fig 2, open symbols) tended to have lower levels of sICAM-1 than did patients re- 
